Having established that ASC controls the extent of amyloid deposition in inflammation-associated amyloidosis in mice and that ASC interacts with SAA via its PYD, we investigated whether natural anti-ASC antibodies exist in human antibody repertoires. The gene discussed is SAA1; the disease is amyloidosis.